3rd Annual reimagine Health Research Symposium: Intervention & Prevention

Add to iCal Calendar 0

Date(s) - 21 Jan 2021
12:00 AM - 12:00 AM


Symposium will address the global need for effective disease treatment and prevention strategies and to solve underlying health disparities.


About this Event

The 3rd Annual reimagine Health Research Symposium will focus on current topics in the areas of Intervention and Prevention of important diseases that are impacting humankind. The symposium will emphasize approaches for a variety of diseases and crises including COVID-19, cancer, opioid addiction, and the challenge of needing to develop novel antibiotics. Attendees will learn from and engage with leading experts who will present and discuss contemporary treatment and prevention strategies in the areas of drug discovery, vaccine development, addiction management, the use of artificial intelligence, as well as ethical and social factors contributing to these approaches.


Who is invited to this event?

The event is open to the public. We highly recommend researchers and healthcare professionals to attend. We also welcome students, educators and the general public to attend this valuable conference. Early registration is encouraged.

To request disability-related accommodations that would ensure your full participation in this event, please contact: COMPHX-ResearchOffice@arizona.edu.


Thanks to our generous sponsors, the Arizona Biomedical Research Centre and the Flinn Foundation, there is no cost to attend the virtual symposium.



This symposium will take place virtually via Zoom Webinar hosted by The University of Arizona College of Medicine – Phoenix.



Visit our website to learn more about the speakers!

Keynote Speaker


Gary Nabel, MD, PhD

ModeX Therapeutics

Topic: Vaccines


Featured Speakers


Regina Barzilay, PhD

Massachusetts Institute of Technology

Topic: AI in Antibiotic Discovery and Oncology Drug Development


Julie E. Bauman, MD, MPH

University of Arizona Cancer Center

Topic: Cancer Immunotherapy


Jolene Bowers, PhD

Translational Genomics Research Institute

Topic: COVID-19 Genomic Epidemiology


Tom Broker, PhD

University of Alabama at Birmingham School of Medicine

Topic: Development of anti-HPV Drugs


Marilyn Glassberg, MD

University of Arizona College of Medicine – Phoenix

Topic: COVID-19 Clinical Trials and Pulmonary Fibrosis


William Holland, MD

Banner Health

Topic: Banner System Response to the COVID-19 Pandemic


Sam Lee, PhD

Cocrystal Pharma Inc.

Topic: Discovery and Development of Antivirals


Purnima Madhivanan, MBBS, MPH, PhD

UArizona Mel and Enid Zuckerman College of Public Health

Topic: HPV Vaccination


Grant McFadden, PhD

Arizona State University

Topic: Virotherapy


Terrence Stull, MD

Phoenix Children’s Hospital Research Institute

Topic: Bacterial Vaccine Polypeptides


Tricia Wright, MD, MS

University of California San Francisco

Topics: Addiction Medicine